Biomarkers of Endometrial Receptivity
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeUp to 36
SponsorThe Institute of Molecular and Translational Medicine, Czech Republic
About this trial
Analysis of proteins from cervical mucus will be done in patients undergoing infertility treatment (fresh or frozen embryo transfer). Cervical mucus will be analysed for potential new biomarkers of endometrium receptivity. Comparison of the peptide spectrum will be done for the pregnant and not pregnant patients.
Eligibility criteria
Qualifiers
female aged less than 37 years (maximally 36y + 364d)
no smoker
normal menstrual cycles lasting between 25 to 35 days
had been infertile for less than five years
Disqualifiers
genetic disease
metabolic and/or endocrine disorders
polycystic ovary syndrome (defined by the Rotterdam criteria)
women with prior diagnosis of endometriosis or adenomyosis
Trial design
Treatments tested in this trial
- Cervical mucus will be collected from patients undergoing IVF
- Cervical mucus will be collected from patients undergoing transfer of cryopreserved embryos
Treatment groups
476 Participants
are divided into 2 treatment groupsSponsors and collaborators
The Institute of Molecular and Translational Medicine, Czech Republic
Lead sponsor
University Hospital Olomouc
Collaborator
Brno University Hospital
Collaborator
Source ClinicalTrials.gov